Hg. Preiksaitis et Lg. Laurier, PHARMACOLOGICAL AND MOLECULAR CHARACTERIZATION OF MUSCARINIC RECEPTORS IN CAT ESOPHAGEAL SMOOTH-MUSCLE, The Journal of pharmacology and experimental therapeutics, 285(2), 1998, pp. 853-861
The muscarinic receptor subtypes that mediate cholinergic responses in
cat esophageal smooth muscle were examined, Antagonist effects on car
bachol-induced and nerve-evoked contractions were studied in vitro usi
ng muscle strips from the distal esophagus. Antagonists displayed simi
lar relative selectivities in suppressing carbachol and nerve-mediated
responses as follows: 4-diphenylacetoxy-N-methylpiperidine (4-DAMP) >
zamifenacin > para-fluoro-hexahydrosiladiphenidol > pirenzepine > AF-
DX 116 > methoctramine, indicating that these responses are mediated b
y the same receptor subtype. 4-DAMP, pirenzepine and methoctramine eff
ects on carbachol responses gave pA(2) values characteristic of the M-
3 receptor in both the circular muscle (9.25 +/- 0.12, 6.79 +/- 0.09 a
nd 6.04 +/- 0.11, respectively) and longitudinal muscle (9.46 +/- 0.14
, 7.25 +/- 0.07 and 6.10 +/- 0.06, respectively). Reverse transcriptio
n-polymerase chain reaction analysis was done using primer sequences b
ased on the cloned human muscarinic receptor subtypes. Messenger RNA f
or the m(3) receptor was readily identified, whereas m(2) was not dete
cted in esophageal muscle, but was present in cardiac muscle. Sequence
homology between the amplified products from cat tissue and the corre
sponding human m(2) and m(3) receptors genes were 93% and 89%, respect
ively. In the cat esophagus, the M-3 receptor mediates functional resp
onses and messenger RNA for the corresponding molecular form of this r
eceptor is abundant in this tissue.